INC.

China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

by

HANGZHOU, China, June 16, 2023 /PRNewswire/ — China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company“), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on June 15, 2023, the Company has received a notification letter from Nasdaq Listing Qualifications … Read more

Evofem Biosciences Announces Financial Results for the First Quarter of 2023

by

— Increased net product revenue 37% in the first quarter of 2023 vs. prior year quarter — — Reduced operating expenses 72% — — Decreased loss from operations by 88% — — Reaffirms path to positive EBITDA — SAN DIEGO, June 16, 2023 /PRNewswire/ — Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced financial results for … Read more

Core Sound Imaging Announces Studycast & Us2.ai Partner Integration

by

Core Sound Imaging and Us2.ai finalize integration agreement. Us2.ai joins Studycast Integration Program, bringing AI-automated Echocardiography analysis and decision support tools  into clients’ imaging and reporting solution. Us2.ai is an FDA cleared app that reports on heart structure and function, with fully automated analyses of ALL heart chambers using both 2D and Doppler views, rendering a … Read more

Novavax entregará la vacuna XBB COVID monovalente según la recomendación VRBPAC de la FDA para el otoño

by

­­- Novavax está preparado para entregar la vacuna XBB COVID monovalente a base de proteínas de acuerdo con la recomendación VRBPAC de la FDA para el otoño Novavax ha desarrollado una candidata a vacuna contra la COVID XBB.1.5 monovalente a base de proteínas y se está fabricando a escala comercial con la intención de estar … Read more

Actinium Pharma to Present at the Maxim Healthcare Virtual Conference

by

NEW YORK, June 16, 2023 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that the Company will participate in a fireside chat at the Maxim Healthcare Virtual Conference on Wednesday, June 21, 2023 at 12:30 PM EST. This conference will be … Read more

Azitra, Inc. Announces Pricing of Initial Public Offering

by

BRANFORD, Conn., June 15, 2023 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today announced the pricing of its initial public offering of 1,500,000 shares of common stock at a public offering price of $5.00 … Read more

Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall

by

Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale with the intent to be in market during the fall vaccination campaign Novavax shared data demonstrating that its XBB.1.5 COVID vaccine candidate induces functional immune responses to XBB subvariants including XBB.1.5, XBB.1.16 and XBB.2.3 If authorized, Novavax’s protein-based vaccine candidate would be … Read more

Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall

by

Novavax has developed a protein-based monovalent XBB.1.5 COVID vaccine candidate and is manufacturing at commercial scale with the intent to be in market during the fall vaccination campaign Novavax shared data demonstrating that its XBB.1.5 COVID vaccine candidate induces functional immune responses to XBB subvariants including XBB.1.5, XBB.1.16 and XBB.2.3 If authorized, Novavax’s protein-based vaccine … Read more

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

by

SOUTH PLAINFIELD, N.J., June 15, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 12, 2023, the company approved non-statutory stock options to purchase an aggregate of 11,260 shares of its common stock and 17,660 restricted stock units (“RSUs”), each representing the right to receive one share of its common stock upon … Read more

Medifast Announces Quarterly Dividend

by

BALTIMORE, June 15, 2023 /PRNewswire/ — Medifast (NYSE: MED), the company behind the health and wellness community, OPTAVIA®, today announced that its Board of Directors has declared a $1.65 quarterly cash dividend to its stockholders. The quarterly cash dividend of $1.65 per share is payable on August 8, 2023, to stockholders of record as of the … Read more